Table 2 Age and sex distribution of the study cohort of users of oral antifungals*
From: Risk of serious skin disorders among users of oral antifungals: a population-based study
Fluconazole | Griseofulvin | Itraconazole | Ketoconazole | Terbinafine | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | |
Sex | ||||||||||
Women | 24,236 | (90) | 2,003 | (41) | 11,474 | (75) | 394 | (53) | 6,017 | (43) |
Men | 2,756 | (10) | 2,938 | (59) | 3,855 | (25) | 343 | (47) | 7,842 | (57) |
Age | ||||||||||
20–39 | 13,742 | (51) | 1,585 | (32) | 7,678 | (50) | 334 | (45) | 3,927 | (28) |
40–59 | 10,340 | (38) | 2,210 | (45) | 5,848 | (38) | 267 | (36) | 6,281 | (45) |
60–69 | 1,767 | (7) | 737 | (15) | 1,150 | (8) | 91 | (12) | 2,338 | (17) |
70–79 | 1,143 | (4) | 409 | (8) | 653 | (4) | 45 | (6) | 1,313 | (9) |
Total | 26,992 | 4,491 | 15,329 | 737 | 13,859 | |||||